Proline bis-amides as potent dual orexin receptor antagonists

被引：63

作者：

Bergman, Jeffrey M. ^{[1
]}

Roecker, Anthony J. ^{[1
]}

Mercer, Swati P. ^{[1
]}

Bednar, Rodney A. ^{[1
]}

Reiss, Duane R. ^{[2
]}

Ransom, Richard W. ^{[2
]}

Harrell, C. Meacham ^{[2
]}

Pettibone, Douglas J. ^{[2
]}

Lemaire, Wei ^{[2
]}

Murphy, Kathy L. ^{[2
]}

Li, Chunze ^{[3
]}

Prueksaritanont, Thomayant ^{[3
]}

Winrow, Christopher J. ^{[2
]}

Renger, John J. ^{[2
]}

Koblan, Kenneth S. ^{[2
]}

Hartman, George D. ^{[1
]}

Coleman, Paul J. ^{[1
]}

机构：

[1] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA

[2] Merck Res Labs, Dept Depress & Circadian Disorders, West Point, PA 19486 USA

[3] Merck Res Labs, Dept Drug Metab, West Point, PA 19486 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 04期

关键词：

D O I：

10.1016/j.bmcl.2008.01.001

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of OX2R/OX1R dual orexin antagonists was prepared based on a proline bis-amide identified as a screening lead. Through a combination of classical and library synthesis, potency enhancing replacements for both amide portions were discovered. N-methylation of the benzimidazole moiety within the lead structure significantly reduced P-gp susceptibility while increasing potency, giving rise to good brain penetration. A compound from this series has demonstrated in vivo central activity when dosed peripherally in a pharmacodynamic model of orexin activity. Published by Elsevier Ltd.

引用

页码：1425 / 1430

页数：6

共 50 条

[31] The orexin story and orexin receptor antagonists for the treatment of insomnia
Muehlan, Clemens
Roch, Catherine
Vaillant, Cedric
Dingemanse, Jasper
JOURNAL OF SLEEP RESEARCH, 2023, 32 (06)
[32] Novel amides as potent and selective histamine H3 receptor antagonists
Nirogi, Ramakrishna
Shinde, Anil
Kambhampati, Ramasastri
Deshpande, Amol
Dwarampudi, Adireddy
Gangadasari, Narsimhareddy
Cheppala, Atreya
Rambabu, Namala
Kandikere, Vishwottam
Jayarajan, Pradeep
Muddana, Nageswararao
Ahmad, Ishtiyaque
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
[33] Discovery of spiropiperidine-based potent and selective Orexin-2 receptor antagonists
Fujimoto, Tatsuhiko
Tomata, Yoshihide
Kunitomo, Jun
Hirozane, Mariko
Marui, Shogo
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (21) : 6409 - 6413
[34] An Efficient Synthesis of Symmetrical N,N′-Alkylidene bis-Amides Catalyzed by a Heteropolyacid
Maleki, Behrooz
Zonoz, Farrokhzad Mohammadi
Akhlaghi, Hossien Ali
ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL, 2015, 47 (05) : 361 - 367
[35] Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia
Chakraborty, Dwaipayan Sarathi
Choudhury, Shouvik
Lahiry, Sandeep
SLEEP SCIENCE, 2023, 16 (02) : 256 - 264
[36] Safety of dual orexin receptor antagonists: a real-world pharmacovigilance study
Sun, Yu
Xu, Tao
Xu, Hongbin
EXPERT OPINION ON DRUG SAFETY, 2025,
[37] Dual orexin receptor antagonists increase sleep and cataplexy in wild type mice
Mahoney, Carrie E.
Mochizuki, Takatoshi
Scammell, Thomas E.
SLEEP, 2020, 43 (06) : 1 - 17
[38] Structural changes in the crystal packing of highly hindered symmetrical vicinal bis-amides
Jimenez, Claudio A.
Belmar, Julio B.
Delgado, Fernando S.
Julve, Miguel
Ruiz-Perez, Catalina
CRYSTENGCOMM, 2007, 9 (09): : 746 - 752
[39] A simple synthesis of ferrocenyl bis-amides by a Ugi four-component reaction
Akbarzadeh, Roya
Mirzaei, Peiman
Bazgir, Ayoob
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2010, 695 (21) : 2320 - 2324
[40] Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulators
Gotter, Anthony L.
Garson, Susan L.
Stevens, Joanne
Munden, Regina L.
Fox, Steven V.
Tannenbaum, Pamela L.
Yao, Lihang
Kuduk, Scott D.
McDonald, Terrence
Uslaner, Jason M.
Tye, Spencer J.
Coleman, Paul J.
Winrow, Christopher J.
Renger, John J.
BMC NEUROSCIENCE, 2014, 15

← 1 2 3 4 5 →